Korea Investment CORP Buys Shares of 99,629 HCA Healthcare, Inc. $HCA

Key Points

• Korea Investment CORP purchased 99,629 shares of HCA Healthcare during the second quarter, valued at approximately $38.8 million. Institutional investors and hedge funds collectively own 62.73% of HCA’s outstanding shares.
• Analysts maintain a generally positive outlook, with 14 Buy, eight Hold and one Sell rating. HCA has a “Moderate Buy” consensus rating and an average price target of $462.64, despite several recent target reductions.
• HCA exceeded quarterly expectations, reporting $7.59 in adjusted earnings per share and $20.23 billion in revenue, with revenue up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, equivalent to a 0.7% annual yield.

Korea Investment CORP purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 99,629 shares of the company's stock, valued at approximately $38,844,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $5,069,974,000. State Street Corp lifted its holdings in HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company's stock worth $3,532,563,000 after purchasing an additional 76,039 shares during the period. Capital World Investors increased its stake in HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company's stock valued at $2,334,040,000 after buying an additional 40,086 shares during the period. Geode Capital Management LLC raised its holdings in HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock worth $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at $1,262,513,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently weighed in on HCA shares. Robert W. Baird reduced their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a research report on Monday, July 27th. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. UBS Group cut their price objective on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating for the company in a research report on Monday, July 27th. Truist Financial cut their target price on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Finally, Morgan Stanley decreased their price target on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Trading Up 5.6%

NYSE:HCA opened at $429.08 on Friday. The business's fifty day moving average price is $397.16 and its 200 day moving average price is $444.14. The firm has a market capitalization of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.84 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source